If you have been reading about GLP-1 analogue and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-04-30. Numbers and descriptions here follow the published literature rather than marketing material.
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released by intestinal L cells after food intake. The natural hormone acts on pancreatic and central receptors but is degraded within minutes by dipeptidyl peptidase-4 and other peptidases. Semaglutide belongs to the class of long-acting GLP-1 receptor agonists, a group distinguished by structural changes that slow breakdown and extend circulation time. Its development followed earlier short-acting analogues and reflects a general strategy in peptide drug design: preserve receptor activity while blocking proteolytic clearance.
Three structural changes define the molecule. At position 8 an alpha-aminoisobutyric acid residue replaces alanine, which blocks dipeptidyl peptidase-4 cleavage. At position 34 arginine replaces lysine, and at position 26 a lysine carries a C18 fatty diacid attached through a short linker. The fatty chain binds serum albumin, and this albumin association reduces renal filtration and enzymatic attack. The unchanged backbone retains the receptor contacts that produce signalling. The free base has the formula C187H291N45O59 and a molecular weight near 4114 daltons.
Receptor activation follows the canonical Gs pathway: binding increases intracellular cyclic AMP, which promotes protein kinase A activity. In pancreatic beta cells this amplifies glucose-dependent insulin release, so secretion rises when blood glucose is high and changes little when it is low. The same signalling suppresses glucagon release from alpha cells and slows gastric emptying. Receptors in the hypothalamus and brainstem are thought to contribute to reduced appetite and lower energy intake. Which of these effects dominates clinical outcomes remains an area of active study.
The compound binds the GLP-1 receptor on pancreatic beta cells and other tissues, activating a G-protein signaling cascade that raises intracellular cyclic AMP. This action increases glucose-dependent insulin secretion when blood glucose is elevated, while binding also slows gastric emptying and reduces glucagon release. In the central nervous system, receptor activation in the hypothalamus and brainstem contributes to reduced appetite. The fatty acid chain binds albumin, which protects the peptide from renal filtration and enzymatic degradation. This albumin binding is central to its extended circulation time.
Native GLP-1 is degraded rapidly by dipeptidyl peptidase-4. Semaglutide resists this cleavage because alanine at position 8 is replaced by alpha-aminoisobutyric acid. A second substitution at position 34 introduces arginine, which further stabilizes the peptide. The most distinctive modification is a spacer and C18 fatty diacid attached at lysine 26, enabling strong albumin affinity. These three changes together produce a half-life measured in days rather than minutes, and the same structural logic underlies other long-acting analogs in this class.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1, a hormone released from intestinal L-cells after food intake. It contains 31 amino acids and differs from native GLP-1 through modifications that slow enzymatic breakdown. The peptide was developed to extend the short circulating half-life of endogenous GLP-1, which is measured in minutes. Researchers introduced the compound in the early 2010s. Two backbone changes and a fatty acid side chain define its structure, distinguishing it from earlier GLP-1 receptor agonists.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C187H291N45O59 | free base, without counter-ion |
| Molecular weight | About 4114 Da | peptide backbone plus attached lipid chain |
| Plasma half-life | About 165 hours | supports once-weekly dosing in humans |
| Plasma protein binding | Greater than 99 percent | attributed mainly to serum albumin |
| Receptor target | GLP-1 receptor | Gs-coupled, raises intracellular cyclic AMP |
The 1980 Familia/323 was the first front-engine, front-wheel-drive vehicle from Mazda since the R130. This generation of 323 was Wheels magazine's car of the year for 1980. The existing station wagon version, simply a facelifted version of the previous rear-drive model (fitted with the square headlights and grille from the new model), was sold in parallel with the BD. The wagon was available with either three or five doors and was equipped either with the old 1272 cc TC engine or the 1415 cc UC. The 1.4 was replaced from 1983 with the newly developed 1490 cc E5 engine. The TC 1.3 produces 60 PS (44 kW) while the larger versions offer 70 PS (51 kW). By 1985, the old 1.3 was replaced by the 1296 cc E3 engine with 68 PS (50 kW); it was only available with the three-door station wagon body.
=== Cryopulverization === Samples with a tough extracellular matrix, such as animal connective tissue, some tumor biopsy samples, venous tissue, cartilage, seeds, etc., are reduced to a fine powder by impact pulverization at liquid nitrogen temperatures. This technique, known as cryopulverization, is based on the fact that biological samples containing a significant fraction of water become brittle at extremely cold temperatures. This technique was first described by Smucker and Pfister in 1975, who referred to the technique as cryo-impacting. The authors demonstrated cells are effectively broken by this method, confirming by phase and electron microscopy that breakage planes cross cell walls and cytoplasmic membranes. The technique can be done by using a mortar and pestle cooled to liquid nitrogen temperatures, but use of this classic apparatus is laborious and sample loss is often a concern. Specialised stainless steel pulverizers generically known as Tissue Pulverizers are also available for this purpose. They require less manual effort, give good sample recovery and are easy to clean between samples. Advantages of this technique are higher yields of proteins and nucleic acids from small, hard tissue samples - especially when used as a preliminary step to mechanical or chemical/solvent cell disruption methods mentioned above.
In 2021, Kennedy opposed FEMA's effort to restructure its NFIP flood insurance program after changes the agency made caused insurance rates to skyrocket in Louisiana, prompting 8.5% of families to drop federal coverage. Kennedy said FEMA's Risk Rating 2.0 was "robbing Louisiana families of the flood protection they need for their homes". He has asked FEMA officials to disclose the algorithm used in Risk Rating 2.0 so it can demonstrate why rates increased 128% in Louisiana, but Millman, the firm that developed Risk Rating 2.0, and FEMA have refused to disclose the algorithm as of 2024. Kennedy introduced the Flood Insurance Pricing Transparency Act to try to force FEMA to disclose the information.
At this time, the Selous Scouts comprised about 120 personnel and all of its officers were white. Black soldiers were offered bonuses that almost doubled their salary if they agreed to serve with the Selous Scouts. The unit was named after the British explorer Frederick Selous (1851–1917) and its motto was pamwe chete—a Shona phrase meaning "all together", "together only" or "forward together". The charter of the Selous Scouts directed them to "the clandestine elimination of terrorism both within and without the country". The name Selous Scouts had previously been attached to the Rhodesian Armoured Car Regiment of the Federal Army of Rhodesia and Nyasaland. The South African Police's Special Branch provided funding for the Selous Scouts. This formed part of the South African Government's extensive support for the Rhodesian counterinsurgency effort. Many South African Defence Force personnel served in the Selous Scouts between 1973 and 1979, including during operations in Rhodesia, Mozambique and Zambia. After the South African Government publicly withdrew the South African Police units which had been deployed to Rhodesia in 1975 SADF personnel continued to serve with the Selous Scouts. A witness who testified at the post-Apartheid South African Truth and Reconciliation Commission stated that the Selous Scouts were covertly funded by the South African Police and South African police officers also served in the unit.
Sources: en.wikipedia.org
Although Franz Joseph ceded no territory to the Kingdom of Prussia after the Austrian defeat in the Austro-Prussian War, the Peace of Prague (23 August 1866) settled the German Question in favour of Prussia, which prevented the unification of Germany from occurring under the House of Habsburg. Franz Joseph was troubled by nationalism throughout his reign. He concluded the Austro-Hungarian Compromise of 1867, which both granted greater autonomy to Hungary and created the dual monarchy of Austria-Hungary. He ruled peacefully for the next 45 years, but suffered multiple personal tragedies: the execution of his brother Emperor Maximilian I of Mexico in 1867, the death by suicide of his son Rudolf in 1889, and the assassinations of first his wife Elisabeth in 1898 and then his nephew and heir presumptive, Archduke Franz Ferdinand, in 1914. After the Austro-Prussian War, Austria-Hungary turned its attention to the Balkans, then a hotspot of international tension due to Austria's interests conflicting with both the Ottoman and Russian Empires. The Bosnian Crisis resulted from Franz Joseph's 1908 annexation of Bosnia and Herzegovina, already occupied by his troops since the Congress of Berlin (1878). On 28 June 1914, the assassination of Archduke Franz Ferdinand in Sarajevo resulted in Austria-Hungary's declaration of war against the Kingdom of Serbia, an ally of the Russian Empire. This activated a system of alliances declaring war on each other, resulting in World War I. After ruling his domains for almost 68 years, Franz Joseph died in 1916.
Coronary artery disease, also known as ischemic heart disease, is caused by atherosclerosis—a build-up of fatty material along the inner walls of the arteries. These fatty deposits known as atherosclerotic plaques narrow the coronary arteries, and if severe may reduce blood flow to the heart. If a narrowing (or stenosis) is relatively minor then the patient may not experience any symptoms. Severe narrowings may cause chest pain (angina) or breathlessness during exercise or even at rest. The thin covering of an atherosclerotic plaque can rupture, exposing the fatty centre to the circulating blood. In this case a clot or thrombus can form, blocking the artery, and restricting blood flow to an area of heart muscle causing a myocardial infarction (a heart attack) or unstable angina. In the worst case this may cause cardiac arrest, a sudden and utter loss of output from the heart. Obesity, high blood pressure, uncontrolled diabetes, smoking and high cholesterol can all increase the risk of developing atherosclerosis and coronary artery disease.
Several genera, including Asian coral snakes (Calliophis), burrowing asps (Atractaspis), and night adders (Causus), are remarkable for having exceptionally long venom glands, extending along each side of the body, in some cases extending posterially as far as the heart. Instead of the muscles of the temporal region serving to press out the venom into the duct, this action is performed by those of the side of the body. Considerable variability in biting behavior is seen among snakes. When biting, viperid snakes often strike quickly, discharging venom as the fangs penetrate the skin, and then immediately release. Alternatively, as in the case of a feeding response, some viperids (e.g. Lachesis) bite and hold. A proteroglyph or opisthoglyph may close its jaws and bite or chew firmly for a considerable time. Differences in fang length between the various venomous snakes are likely due to the evolution of different striking strategies. Additionally, it has been shown that the fangs of different species of venomous snakes have different sizes and shapes depending on the biomechanical properties of the snake's prey.
Sources: en.wikipedia.org
Native GLP-1 is a short-lived peptide cleared within one to two minutes by dipeptidyl peptidase-4 and related enzymes. Semaglutide keeps the receptor-binding backbone but adds substitutions and a lipid chain. These changes block the main cleavage site and allow reversible albumin binding, extending the half-life to roughly 165 hours.
Albumin is the most abundant protein in plasma and carries molecules that bear fatty-acid chains. Binding shields the peptide from renal filtration and from peptidases, keeping a circulating reservoir. Slow release from this reservoir produces sustained receptor occupancy and supports infrequent dosing.
The insulinotropic effect is glucose-dependent, meaning secretion increases mainly when glucose is elevated. This property is often described as lowering the chance of hypoglycaemia when the compound is used alone. Other glucose-lowering agents used at the same time can still cause low blood glucose.
It is a synthetic analog of GLP-1 produced through medicinal chemistry to resist enzymatic degradation. The design goal was longer circulation than the native hormone.